Mutation in PHC1 implicates chromatin remodeling in primary microcephaly pathogenesis

Salma Awad1, Mohammed S Al-Dosari, Nadya Al-Yacoub

  • 1Department of Genetics, Developmental Genetics Unit.

Human Molecular Genetics
|February 19, 2013
PubMed

Insights

A novel mutation in PHC1 causes primary microcephaly (PM), a brain development disorder. This genetic variant disrupts histone ubiquitination and cell cycle regulation, impacting neuroprogenitor cells.

Area of Science:

  • Genetics
  • Developmental Biology
  • Neuroscience

Background:

  • Primary microcephaly (PM) is a severe neurodevelopmental disorder characterized by reduced brain size, particularly the cerebral cortex.
  • The underlying genetic causes of PM are diverse, highlighting the complexity of early brain development.

Purpose of the Study:

  • To investigate the genetic basis and cellular mechanisms of a novel form of primary microcephaly.
  • To identify the specific gene and mutation responsible for PM in a consanguineous family.

Main Methods:

  • Autozygosity mapping and exome sequencing were employed to identify the causative genetic variant.
  • Functional assays were conducted on patient-derived cells expressing wild-type and mutant PHC1.
  • Cellular processes including protein expression, histone modification, cell cycle progression, and DNA damage repair were analyzed.

Main Results:

  • A novel mutation in PHC1, a polycomb group gene, was identified as the cause of PM.
  • The mutation leads to decreased PHC1 protein, increased Geminin levels, and impaired histone H2A ubiquitination in patient cells.
  • Patient cells exhibit cell cycle defects and aberrant DNA damage repair, which are rescued by PHC1 re-expression.

Conclusions:

  • The findings reveal that mutations in PHC1 disrupt chromatin remodeling, leading to cellular defects underlying primary microcephaly.
  • This study underscores the critical role of PHC1 and histone ubiquitination in neurodevelopment and cell cycle regulation.
  • Aberrant DNA damage repair is a newly identified cellular consequence of PHC1 mutations in PM.